<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03312556</url>
  </required_header>
  <id_info>
    <org_study_id>010189-1</org_study_id>
    <nct_id>NCT03312556</nct_id>
  </id_info>
  <brief_title>Treatment of Supine Hypertension in Autonomic Failure (CPAP)</brief_title>
  <official_title>Treatment of Supine Hypertension in Autonomic Failure With Continuous Positive Airway Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Supine hypertension is a common problem that affects at least 50% of patients with primary
      autonomic failure. Supine hypertension can be severe and complicates the treatment of
      orthostatic hypotension. The purpose of this study is to assess whether continuous positive
      airway pressure (CPAP) decreases blood pressure in autonomic failure patients with supine
      hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Supine hypertension is a common problem that affects at least 50% of patients with primary
      autonomic failure. Supine hypertension can be severe and complicates the treatment of
      orthostatic hypotension. Drugs used for the treatment of orthostatic hypotension (eg,
      fludrocortisone and pressor agents), worsen supine hypertension. High blood pressure may also
      cause target organ damage in this group of patients. The pathophysiologic mechanisms causing
      supine hypertension in patients with autonomic failure have not been defined.

      This study will test the hypothesis that continuous positive airway pressure (CPAP) has an
      acute lowering-BP effect in autonomic failure patients with supine hypertension. CPAP is a
      widely-used treatment for sleep-related breathing disorders including sleep apnea, that uses
      mild air pressure to keep the breathing airways open. It involves using a CPAP machine that
      blows air into a tube connected to a mask placed over the nose, or nose and mouth. For these
      studies, a commercial CPAP device will be used to apply pressure sequentially at 0, 4, 8, 12
      and 16 cm H2O for 1-20 minute each. Depending on the BP response and tolerability to CPAP,
      CPAP may be applied during the night using a CPAP level that was tolerable and showed a
      BP-lowering effect during the acute test.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2017</start_date>
  <completion_date type="Anticipated">December 21, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Supine Systolic Blood Pressure</measure>
    <time_frame>12 hours</time_frame>
    <description>change in supine systolic blood pressure from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary volume</measure>
    <time_frame>12 hours</time_frame>
    <description>Nocturnal urinary volume</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Supine Hypertension</condition>
  <condition>Autonomic Failure</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo pill or patch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous positive airway pressure during the night</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous positive airway pressure (CPAP)</intervention_name>
    <description>Continuous positive airway pressure(CPAP) will be applied during the night starting from 20:00. CPAP level will be determined during an acute CPAP trial.</description>
    <arm_group_label>CPAP</arm_group_label>
    <other_name>CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo pill or patch. Single dose</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with autonomic failure and with supine hypertension from all races

        Exclusion Criteria:

          -  All medical students

          -  Pregnant women

          -  High-risk patients (e.g. heart failure, symptomatic coronary artery disease, liver
             impairment, history of stroke or myocardial infarction)

          -  History of serious allergies or asthma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Denise S Ransby, RN</last_name>
    <phone>(615) 322-3304</phone>
    <email>Autonomics@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Misty Hale, CCRP</last_name>
    <phone>615-343-8649</phone>
    <email>Autonomics@vanderbilt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Autonomic Dysfunction Center/ Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Ransby, RN</last_name>
      <phone>615-322-3304</phone>
      <email>Autonomics@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Misty D Hale, CCRP</last_name>
      <phone>615-343-8649</phone>
      <email>Autonomics@vanderbilt.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Bonnie K Black, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis E Okamoto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Robertson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Italo Biaggioni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfredo Gamboa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyndya A Shibao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andre Diedrich, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>jorge Celedonio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Italo Biaggioni</investigator_full_name>
    <investigator_title>Professor of Medicine and Pharmacology</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>supine hypertension</keyword>
  <keyword>autonomic failure</keyword>
  <keyword>pure autonomic failure</keyword>
  <keyword>multiple system atrophy</keyword>
  <keyword>cpap</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Pure Autonomic Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

